Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine efficacy study for falciparum malaria in India
ACTRN12614000217606Phase 4Recruiting
- Sponsor
- National Institute of Malaria Research
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether and lumefantrine in malaria and Malaria, sponsored by National Institute of Malaria Research. Primary endpoint: WHO-classified treatment outcome. Started Jan 2014; status: recruiting.
02
Drugs
artemetherlumefantrine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12614000217606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000217606.